Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers
Recruiting · NCT06966024 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of DCC-2812 in Participants With Advanced Genitourinary Cancers | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, epithelial neoplasm, kidney cancer, kidney disorder, neoplasm, renal cell carcinoma, transitional cell carcinoma, urinary system disorder, urothelial carcinoma | Recruiting | Phase 1 | 2026-08-18 | NCT06966024 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Deciphera Pharmaceuticals, LLC | 15 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Fox Chase Cancer Center | Philadelphia | United States | 259 |
| NEXT Oncology, Austin | Austin | United States | 1 |
| NEXT Oncology, San Antonio | San Antonio | United States | 2 |
| University of Michigan | Ann Arbor | United States | 538 |
| Vanderbilt- Ingram Cancer Center | Nashville | United States | 2 |
| Washington University School of Medicine | St Louis | United States | 895 |